EUCOPE represents small to mid-sized companies that support, invest and produce the innovative medicines and therapies of the future.
Our members supply cutting-edge treatments that improve and save the lives of millions of patients. As a recognized stakeholder, we work with the European Commission and European Medicines Agency (EMA) to improve and maintain Europe’s competitiveness within the global life sciences industry. so patients have greater and more equitable access to new treatments faster.
At EUCOPE, we provide a platform for discussion on major healthcare topics and developments, provide ad hoc expertise and updates on national market access and HTA issues and ensure that our members’ voices are heard first in the early stages of policy-making and legislative procedures at the EU and Member State level.
Learn more about the benefits of membership with EUCOPE.
The following companies are members of EUCOPE: